|1.||Sakamoto, Atsuhiro: 9 articles (04/2014 - 12/2004)|
|2.||Hirano, Masaharu: 5 articles (09/2014 - 06/2013)|
|3.||Saito, Shigeru: 5 articles (01/2012 - 12/2005)|
|4.||Noguchi, Takayuki: 5 articles (10/2010 - 11/2007)|
|5.||Sezai, Akira: 4 articles (10/2015 - 06/2011)|
|6.||Shiono, Motomi: 4 articles (10/2015 - 06/2011)|
|7.||Jinzaki, Masahiro: 4 articles (09/2014 - 06/2013)|
|8.||Kuribayashi, Sachio: 4 articles (09/2014 - 06/2013)|
|9.||Hara, Kazuhiro: 4 articles (09/2014 - 06/2013)|
|10.||Iino, Misako: 4 articles (09/2014 - 06/2013)|
05/01/2003 - "The present case suggests that landiolol hydrochloride is effective in controlling heart rate in a patient with atrial fibrillation and that the optimal dose should be carefully evaluated for each case."
07/01/2013 - "Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery."
01/01/2012 - "Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery."
01/01/2015 - "Efficacy and safety of landiolol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials."
04/01/2014 - "Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trials."
01/01/2007 - "Landiolol at 0.1 mg/kg was most effective against intubation-induced tachycardia when infused 4 min before intubation in normotensive patients. "
03/01/2004 - "Intravenous administration of an ultra short acting beta-blocker, landiolol hydrochloride, controlled heart rate and improved tachyarrhythmia without significant change of blood pressure. "
03/01/2004 - "Landiolol hydrochloride is effective and useful for the treatment of tachyarrhythmia during beating CABG."
01/01/2015 - "Recently, landiolol, an ultra-short acting β1-selective antagonist, has been reported to be safe and useful for the treatment of supraventricular tachyarrhythmias with reduced left ventricular function. "
01/01/1997 - "Administration of ONO-1101 0.25 or 0.5 mg.kg-1 decreased the incidence of tachycardia. "
07/01/2007 - "Various drugs with or without landiolol (100 microM) were administered before ischemia for 20 min. Preischemic administration of landiolol reduced cardiac cellular damage and improved the recovery of cardiac function by about 40%. "
06/01/2007 - "This study was designed to investigate whether administration of landiolol before or during ischemia protects the myocardium against ischemia-reperfusion (I/R) injury. "
06/01/2007 - "Landiolol has a cardioprotective effect on I/R injury in the rat heart when administered before ischemia."
01/01/2007 - "Before the ischemia, hearts were treated with landiolol (20, 100, or 500 microM) for 15 min (LAN group). "
01/01/2007 - "The authors examined the cardioprotective effect of landiolol, an ultra short-acting, highly selective beta1-blocker, and its role in cardiac work, antioxidative effect, and sarcoplasmic reticulum (SR) function in hearts subjected to ischemia-reperfusion. "
03/01/2015 - "Suppression of HR and rate pressure product was generally more potent(P < .0001), and higher proportions of patients improved supraventricular tachycardia (P < .0001) in the landiolol group. "
08/01/2012 - "The objective of this study was to investigate the efficacy of landiolol hydrochloride, an ultra-short-acting β1-blocker, in patients with post-operative supraventricular tachycardia after pulmonary resection. "
08/01/2012 - "Recurrence of supraventricular tachycardia after stopping landiolol infusion was observed in 17 patients (68%), but all patients without preoperative AF were cured of post-operative AF. "
03/01/2015 - "Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study."
08/01/2012 - "Side effects and recurrence of supraventricular tachycardia after termination of landiolol infusion were also monitored. "
|5.||Atrial Flutter (Flutter, Atrial)
02/01/2010 - "Conversion of atrial flutter to sinus rhythm during landiolol infusion."
08/01/2012 - "The response to continuous intravenous infusion of landiolol was evaluated in 25 patients who developed post-operative atrial fibrillation or atrial flutter after major pulmonary resection. "
07/01/2015 - "Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey."
04/01/2014 - "Results from the multicenter trial (J-Land study) of landiolol versus digoxin in atrial fibrillation (AF) and atrial flutter (AFL) patients with left ventricular (LV) dysfunction revealed that landiolol was more effective for controlling rapid HR than digoxin. "
11/01/2009 - "The efficacy of landiolol was evaluated in 38 patients who, after developing postoperative atrial flutter or fibrillation, with sinus tachycardia and two patients who had a history of paroxysmal atrial fibrillation with frequent atrial extrasystole. "
|7.||Biological Markers (Surrogate Marker)
|3.||Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
|5.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)